Cannabis Research

The University of New Brunswick has announced the post-secondary institution will have a health research chair in cannabis. This will be the first research chair in pharmacological sciences globally, and the second university in New Brunswick to have a cannabis related research chair, after St. Thomas University announced their chair in May — focusing their research […]

by

It’s no secret that cannabis is thought to be an incredibly potent and versatile medicine by millions of people around the world. However, most of the research and documentation has been focused on experiences with two parts of the plant: the flowers and, to a lesser extent, the leaves. But a resurgence of interest in […]

by

It was disappointing to read Dr. Matthew Poling’s misleading column (Eagle, July 23). He criticized my July 15 “Cannabis 101” seminar held at the First United Methodist Church of Bryan, referring to it as a “sales pitch” based on “pseudo-science” that “might have made a 19th century snake oil salesman blush.” National medical cannabis research […]

by

A bipartisan group of Oregon lawmakers joined legislators from across the country on Monday in calling for the federal government to remove marijuana from the list of controlled drugs. If the federal government were to heed the request, it could ease restrictions on cannabis research and banking in states that have legalized the drug. Yet it comes […]

by

When Pittsburgh Steelers wide receiver Martavis Bryant stopped his regular cannabis consumption in order to pass the NFL’s drug test, he encountered an unexpected challenge. Insomnia kept him up at night. “I would get frustrated,” Bryant told Sports Illustrated. “I’d yell, ‘Why can’t I sleep!?’” The answer may have been cannabis withdrawal syndrome, or CWS. […]

by

By Alicia Wallace, The Cannabist Staff The U.S. Drug Enforcement Administration intends to decrease the amount of marijuana it allocates for federally approved research. The DEA has released its proposed 2018 aggregate production quotas (APQ) for substances that fall under the tightest restrictions as Schedule I and II in the federal drug classification; the APQs […]

by

There’s a harsh downside to the boom in marijuana legalization and use on the West Coast: Illegal growers are polluting the environment to an alarming degree and threatening the health of people and rare wildlife in the process. Mourad Gabriel, an ecologist with the Integral Ecology Research Center in northwest California, told Reuters the problem is much […]

by

A bipartisan group of Oregon lawmakers joined legislators from across the country on Monday in calling for the federal government to reclassify marijuana so it’s no longer a Schedule 1 drug. If the federal government were to heed the request, it could ease restrictions on cannabis research and banking in states that have legalized the drug. […]

by

TEL AVIV, Israel, August 7, 2017 /PRNewswire/ — Innovative researchers and scientists, ag-tech, pharma experts, regulators, investors, and entrepreneurs will share their knowledge about the burgeoning medical cannabis industry at CannaTech UK, Britain’s first-ever international Summit for Accelerating Cannabis Innovation. The main event will take place October 26 at The Old Truman Brewery , preceded […]

by

NEW YORK, August 7, 2017 /PRNewswire/ — A market report by Ameri Research Inc. indicates that the global legal cannabis market was valued at $14.3 billion in 2016 and is projected to grow at a CAGR of 21.1% from 2017 to 2024. During the forecast period, the projected demand of cannabis will continue to rise for both […]

by

WASHINGTON — Medical cannabis users reported better “clinically meaningful” health outcomes than non-users, and epilepsy sufferers in particular reported health improvements after using medical cannabis, according to researchers here. In a survey-based study, users of medical cannabis reported experiencing statistically significant better overall quality of life (QoL), satisfaction with their health, less pain, less anxiety, […]

by